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Abstract 
Stigma is a significant difficulty for people who experience psychosis.  To date, there have 
been no outcome measures developed to examine stigma exclusively in people with 
psychosis.  The aim of this study was develop and validate a semi-structured interview 
measure of stigma in psychosis.  An eleven item semi-structured interview measure of stigma 
(SIMS) was developed in consultation with service users who experience psychosis.  79 
participants with experience of psychosis were recruited for the purposes of this study.  They 
were administered the SIMS alongside a battery of other relevant outcome measures to 
examine reliability and validity. A one-factor solution was identified for the SIMS which 
encompassed all ten rateable items.  The measure met all reliability and validity criteria and 
illustrated good internal consistency, inter-rater reliability, test retest reliability, criterion 
validity, construct validity, sensitivity to change and had no floor or ceiling effects.  The 
SIMS is a reliable and valid measure of stigma in psychosis.  It may be more engaging and 
acceptable than other stigma measures due to its interview format.    
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Introduction 
Many outcome measures have been developed to assess the impacts of stigma on service 
users diagnosed with a serious mental illness (SMI).  However, a recent systematic review of 
individual outcome measures of stigma identified that all of the available measures are self-
report measures and not specific to psychosis (Brohan et al., 2010).   Brohan et al (2010) 
identified that the three most widely-used self-report measures of stigma were; the Perceived 
Devaluation and Discrimination Scale (PDD: Link, 1987), the Internalised Stigma of Mental 
Illness Scale (ISMI) (Ritsher et al., 2003), and the Self-Stigma of Mental Illness Scale 
(Corrigan et al., 2006).  Brohan et al (2010) identified that these outlined measure each 
lacked some form of reliability and validity, for example, all did not meet requirements for 
floor and ceiling effects.  Furthermore, as stated, these measures were developed for use with 
individuals experiencing SMI. Arguably SMI’s are not comparable in terms of their 
experiences of stigma which will also hinder reliability and validity.  Those with a 
schizophrenia spectrum disorder are viewed most negatively  by the public (Crisp et al., 
2005; Wood et al., 2014), are most discriminated against (Dinos et al., 2004; Thornicroft et 
al., 2009), have the most intense internalised stigma beliefs, worst social exclusion and 
significantly lower levels of functioning, compared to those with a diagnosis of bipolar 
disorder and depression (Karidi et al., 2015; Oliveria et al., 2015).   
The aim of this study was to develop a reliable and valid semi-structured interview measure 
of stigma in psychosis, in consultation with service users, which can be used to assess and 
monitor change in the impacts of stigma in psychosis. A semi-structured interview measure 
also provides diversity in a saturated pool of self-report measures.  Furthermore, the semi-
structured format of the interview measure offers the flexibility in questioning to identify 
culturally specific aspects of stigma which has been a criticism of the existing self-report 
measures (Semrau et al., 2015).  Outcomes on the semi-structured interview measure of 
stigma (referred to henceforth as the SIMS) were compared  to the ISMI (Ritsher et al., 2003) 
and  stigma scale (King et al., 2007) to examine its ability to measure stigma.  Furthermore, it 
was also compared to outcomes measures of self-esteem, depression, hopelessness, shame 
and recovery, since research indicates that these psychological variables are also related to 
stigma and thus assist with validation (Birchwood et al., 2007; Corrigan et al., 2006; Link et 
al., 2001; Livingston & Boyd, 2010; Michail & Birchwood, 2013; Rüsch et al., 2014). The 
psychometric properties of the SIMS were examined and it was hypothesised that there will 
be good validity in comparison to other relevant measures. Specifically, it was hypothesised 
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that the SIMS will be positively correlated with existing measures of stigma, and with 
measures of depression, hopelessness and shame, and negatively correlated with measures of 
self-esteem and recovery. 
 
Methods 
Development of the SIMS 
Literature review and initial development 
Item generation for the SIMS was derived from a systematic review of qualitative literature 
examining service user perspectives of stigma in psychosis, as described in Wood et al. 
(2015).  Eight studies were included in this review and were analysed using thematic 
synthesis (Thomas & Harden, 2008).    A total of 96 initial codes were identified in the data 
(coding for the SIMS was conducted separately from analysis published in the systematic 
review due to differing aims).  Codes were reviewed by the research team and grouped into 
nine subordinate themes as follows; experienced stigma, perceived stigma, internalised 
stigma (comprising self-esteem, emotions, safety behaviours/avoidance, relationships, 
impacts on experiences of psychosis, treatments, and recovery).   All items related to the 
stigma caused by experiencing psychosis. 
Scoring criteria for the SIMS was developed through examination of a sample of current 
semi-structured measures utilised in psychosis.  The Positive and Negative Syndrome Scale 
(Kay & Opler, 1987), the Psychotic Symptoms Rating Scale (Haddock et al., 1999), and the 
Calgary Depression Scale (Addington et al., 1994) were consulted as they offer an array of 
scoring criteria for consideration. Questions and prompts were developed for each theme to 
assist interviewers in collecting relevant stigma-related information pertaining to each theme, 
in a consistent manner across interviewees.  
Service user consultation and piloting 
A draft version of the SIMS was reviewed by a Service-User Reference Group (SURG) to 
enhance content validity.  The SURG comprised eight service users with lived experience of 
psychosis.  The SURG suggested that the SIMS should include two additional areas of 
questioning; one concerning service users’ understanding of stigma and one regarding the 
positive impacts of stigma. In addition, the SURG offered the following suggestions: to 
Schizophrenia Research 176(2-3):398-403 Oct 2016 
5 
 
provide standard definitions of stigma; to make language more understandable and acceptable 
to service users; and to offer service users an interview agenda in advance to allay any fears 
about questioning.  The SURG also made suggestions regarding the scoring of the SIMS 
preferring a likert scale rating which could be applied to each individual item. The SIMS was 
piloted with two service user researchers in order to further refine questions and prompts, to 
estimate duration of interview and to get feedback regarding the experiences of being 
interviewed using the SIMS.   
Final measure and scoring 
The final SIMS comprised eleven sections, one of which is not scored: understanding of 
stigma (not scored), perceived stigma, experienced stigma, internalised stigma (self-esteem, 
safety behaviours/avoidance, relationships, impacts on experiences of psychosis, treatments, 
positive impacts of stigma, and recovery). All items enquired about the impacts of stigma 
related to experiences of psychosis.   The interview is designed to collect quantitative data 
based on the subjective accounts reported by the interviewee.  Each section is rated on a five-
point likert scale (0-4) by the interviewer where 0 indicates no impact/experience of stigma 
and 4 indicates a severe impact/experience of stigma.  When rating, the interviewer must take 
into consideration the frequency, duration, amount of distress, intensity of distress, and 
impacts on day to day functioning.  All items are rated on the interviewees experiences in the 
past month. Comprehensive guidance to support interrater reliability is incorporated into the 
measure. 
 
Participants 
Participants were recruited from two sources.  Participants were either recruited from (a) the 
Reducing Self-stigma in Psychosis through Engagement in Cognitive Therapy (RESPECT) 
trial, Morrison et al. (2016) or (b) an inner London acute psychiatric inpatient unit.  In both 
(a) and (b) participants were either identified by their care coordinator or via the nursing staff 
on the participating wards.   Participants were included if they were (i) aged between 18-65, 
and (ii) met ICD-10 criteria for schizophrenia, schizoaffective disorder or delusional disorder 
or met criteria for an Early Intervention in Psychosis Service.  Exclusion criteria were 
moderate to severe learning disability, organic impairment, participants not having the 
capacity to consent to research participation, non-English speaking participants, severe 
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thought disorder, and a primary diagnosis of drug and alcohol dependency.  Severe thought 
disorder was determined by the referring clinician.  
Additional outcome measures 
Internalised Stigma of Mental Illness Revised (ISMI-R) scale (Ritsher et al., 2003). The 
ISMI-R is a 29-item questionnaire assessing internalised stigma. This measure was revised by 
the research team in partnership with SURG  such that the term ‘mental illness’ in its original 
form was replaced with ‘mental health problems’.  Higher scores indicate increased 
internalised stigma.  
The Stigma Scale (SS) short version  (King et al., 2007). The SS is a 16-item measure of 
stigma. This shortened version included the subscales of ‘disclosure’ and ‘positive aspects’, 
but not the ‘discrimination’ subscale which is less likely to capture change over time.  Higher 
scores demonstrate higher levels of stigma. 
The Process of Recovery Questionnaire – Short form (QPR (Law et al., 2014)) was used to 
measure user-defined recovery. This is a 15-item questionnaire which was developed 
collaboratively with service users and which measures subjective recovery.    Increased 
scores illustrate higher levels of perceived recovery. 
The Beck Depression Inventory for Primary Care (BDI-7; (Winter et al., 1999)) is a 7-item 
measure of depression. Higher scores indicate increased levels of depression. 
The Beck Hopelessness Scale (BHS; (Beck et al., 1974)) s a 20-item measure of 
hopelessness. Higher scores show increased hopelessness. 
Self-esteem was measured using the Self-Esteem Rating Scale – Short form (SERS-S; 
(Lecomte et al., 2006)), a 20-item questionnaire with higher scores indicating higher self-
esteem.  
Finally, internalised shame was measured using the Internalised Shame Scale (ISS; (Cook, 
1987)), a 30-item questionnaire with higher scores indicating higher levels of shame.  
A measure of psychotic symptoms was not included on the basis of feedback from the SURG, 
who felt that a focus on such symptoms would provide an inconsistent message regarding 
stigma. 
Procedure 
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This study was carried out in three stages of assessment.  Stage one baseline assessments 
involved participants (n=79) completing the SIMS alongside all other measures. Data from 
stage 1 was used to carry out the factor analysis, internal consistency, inter-rater reliability, 
and concurrent validity of the SIMS. The second stage follow-up involved a proportion of 
participants (n=25) completing the SIMS again at a 4 month time point to examine for test-
retest reliability.  These participants had all been included in the RESPECT study (Morrison 
et al., 2016).   Stage 3 followed up stage 2  participants (n=28,including 3 additional 
participants who were unavailable at stage 2), completing the SIMS and all other measures at 
a 7 month time point in order to examine for sensitivity to change.  
Statistical Analysis 
All data analysis was conducted using  IBM SPSS version 20 (IBM Corp, 2011).   Where 
whole outcome measures were missing, data would be excluded pairwise for the respective 
analysis.   Where less than 20% of individual items were missing from outcome measures, 
these would be replaced with the measure mean.  Data was initially checked for normality 
through examination of skewness and kurtosis (Kim, 2013). 
Initially, individual SIMS items were compared using the Pearson’s correlation coefficient to 
ensure that no items were either extremely highly or poorly correlated.  All SIMS items were 
entered into an exploratory Principal Components Analysis (PCA) with Direct Oblimin 
rotation, and internal consistency was examined for the identified factor’s items.  Test retest 
reliability was tested for by examining the Pearson correlation coefficients between the SIMS 
total scores at stage 1 and 2. The SIMS was compared to the ISMI-R to examine for criterion 
validity using Pearson’s correlation analysis.  The ISMI-R was chosen as it is currently the 
most reliable measure of stigma (Brohan et al., 2010).   Construct validity was examined 
through comparisons of the SIMS to all other measures using Pearson’s correlation analysis. 
Sensitivity to change was calculated by comparing the change score (stage 1 mean score 
minus the stage 3 mean score) of the SIMS to change score of all other measures.  Where 
relevant, correlation coefficients were compared for significance using the Fishers z 
calculation.  Floor and ceiling effects were determined as present if more than 15% of the 
sample scored the minimum (0) or maximum (40) score on the SIMS (Terwee et al., 2007).  
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Results 
Participant demographics 
A total of 79 participants took part in the study.  Demographics can be seen in table 1. 
[INSERT TABLE 1 HERE] 
 
Initial data scrutiny 
Individual items from the SIMS were initially screened for their relationship with one another 
(table 2).  If items were either high or low item correlations (<.200 or>.900) they would be 
removed, but none met this criteria.  Items 9 (0.142 to 0.417) and 10 (-0.175 to -0.296) had 
the lowest item correlations.  Items 9 and 10 also had the lowest endorsements (table 2) but 
all ten items were included in the factor analysis. 
[INSERT TABLE 2 HERE] 
Examination of reliability 
Principal Components Analysis 
The examination of the scree plot (figure 1) and eigenvalues led to only one factor being 
identified.  This factor explained 51.97% of the variance.  Factor loadings are shown in table 
2. As a consequence of the one factor solution, no sub-categories were identified within the 
interview measure. The full ten items will therefore be used for subsequent reliability and 
validity analysis. 
Internal Consistency 
Internal consistency was examined through the use of the Cronbach’s Alpha statistic.  The 
SIMS items showed excellent internal consistency with a Cronbach’s Alpha score of α=0.87 
(Nunnally & Bernstein, 1994). Intraclass Correlations (ICCs), using a two way mixed model, 
were also examined to test for reliability.  The measure had a fair ICC of 0.391 (CI: .307 - 
.489, p<0.001). 
Inter-rater Reliability 
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The SIMS was also shown to have good inter-rater reliability across three raters. Authors LW 
and GE rated three interviews and had an ICC of 0.874, LW and EB also rated three 
interviews and had an ICC of 0.959, both illustrating almost perfect agreement (Landis & 
Koch, 1977).   
Test-retest Reliability 
Participants (n=25) scored a mean total of 23.76 (SD: 6.66) at stage 1 and a mean of 20.03 
(SD: 8.02) at stage 2.  The SIMS showed good test retest reliability with a significant ICC of 
0.563 (CI: 0.214 - 0.784, p<0.01).   
Examination of Validity 
Means and standard deviations for all measures used to examine validity are shown in table 3. 
The Pearson correlation coefficients for each measure are also shown in table 4.   
[INSERT TABLE 3 HERE] 
Criterion validity 
The SIMS illustrated a significant strong positive correlation with the ISMI-R (table 2).  The 
coefficient was above 0.7 illustrating that it meets the gold standard of criterion validity 
(Terwee et al., 2007). 
Construct validity 
The SIMS illustrated significant correlations with all other outcomes (table 4).  The SIMS 
and SS were highly correlated illustrating that the SIMS is valid in measuring the broad 
construct of stigma.  The SIMS was also highly correlated with the BDI and BHS 
highlighting the relationship between stigma, depression and hopelessness as highlighted in 
the literature (Link et al., 2001; Lysaker et al., 2007).  The SIMS was also highly correlated 
with the SERS and ISS showing a strong relationship between stigma, shame and low self-
esteem (Link et al., 2001).   The SIMS illustrated a significant positive correlation with the 
QPR.   
 
 [INSERT TABLE 4 HERE] 
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Sensitivity to Change 
[INSERT TABLE 5 HERE] 
Pearson correlation coefficients and follow-up descriptive statistics for all measures can be 
found in table 3.  The SIMS was found to have significant correlations with all measures.  
The strongest relationship of change related particularly to the ISS and SERS indicating that 
changes in stigma relate most strongly to shame and self-esteem.  It also has a strong 
relationship with the BDI, BHS and QPR.  The correlations highlight that the SIMS had 
larger sensitivity to change correlation coefficients against all  outcomes compared to the 
ISMI-R, with the SERS, ISS and QPR being statistically significant (BDI: Fishers z=0.88 , 
p=0.190; BHS: Fishers z=1.34 , p=0.090 ; SERS: Fishers z= -2.5, p<.01 ; ISS: Fishers z= 
1.73, p<.05 ; QPR: Fishers z=-.659 , p<.05).  The SIMS also had larger sensitivity to change 
correlation coefficients with the SERS, ISS, and QPR compared to the SS but the difference 
was not statistically significant (SERS: Fishers z= -1.41, p=0.0793; ISS: Fishers z= 0.18, 
p=0.428 ; QPR: Fishers z= 0.352, p=0.703).  
 
Floor and Ceiling effects 
The SIMS did not illustrate any floor of ceiling effects.  No participants scored the minimum 
score of 0 and no participants scored the maximum score of 40.  As shown in table 2, the 
minimum score on the SIMS was 2 and the maximum was 36. 
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Discussion 
The aim of this study was to develop and examine the psychometric properties of the SIMS.  
Analysis demonstrated that it is a reliable and valid tool to assess change in stigma in 
psychosis.  The SIMS was relatively quick to administer compared to other semi-structured 
tools and appeared to have high content validity.   The SIMS is developed to be the first 
stigma measure specifically for people who experience psychosis.  Having a specific target 
population increases the validity of the measure (Terwee et al., 2007).  This may explain why 
the SIMS was shown to have better sensitivity to change and concurrent validity than the 
other comparable stigma measures.  Targeting this population enabled specific questions to 
be included examining the impacts of stigma on auditory hallucinations and unusual beliefs.  
Results illustrated that this was an important subscale which contributed to the reliability and 
validity statistics.  This accords with other research in the field as internalised stigma has also 
been found to be associated with both positive symptoms (Caveleti et al., 2014) and negative 
symptoms (Hill & Startup, 2013) of psychosis. Conversely, the SIMS examined impacts of 
stigma which could potentially be important to people with other mental health experiences 
however this would need to be examined for reliability and validity in future research. 
One of the benefits of the SIMS is that it utilises a semi-structured interview format where 
most previous measure are self-report in nature (Brohan et al., 2010).  An interview measure 
has a number of advantages over standard self-report measures.  It improves the reliability 
since interviewers are on-hand to clarify questions and concepts for interviewees, and  
improve participant engagement (Phellas et al., 2011), which is likely to be of particular 
importance when discussing issues of a sensitive nature, such as  personal accounts of stigma.  
The SIMS can be used by clinicians as a meaningful clinical tool to assess stigma and offers 
various prompts to engage service users in a meaningful discussion about stigma.  Talking 
about stigma has been shown to reduce stigma (Corrigan et al., 2013), therefore 
administration of the measure alone may be of therapeutic benefit and reduce the internalised 
stigma of interviewees.   
The SIMS is also the first outcome measure to delineate and examine the specific 
psychological impacts of stigma.  The SIMS can extract rich information regarding the 
psychological functioning of service users.  This is valuable information since it can enable 
clinicians to offer appropriate psychological support.  For example, the SIMS scrutinises 
safety behaviours, emotional responses and impacts on relationships which are fundamental 
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to psychological models.  An increasing number of clinical trials have been conducted 
examining the efficacy of stigma based interventions, mainly drawing upon cognitive 
behavioural therapy (CBT) theory, and with varying results (Knight et al., 2006; Lucksted et 
al., 2011; Morrison et al., 2016).  One criticism of these studies is the lack of specificity in 
the outcome measures they use in regard to psychological mechanisms (Wood et al., 2016).  
The SIMS may fill this gap by examining specific psychological mechanisms relevant to 
stigma.   
There were a number of limitations in this study. One of the limitations was the time points in 
which the test retest and sensitivity to change follow-ups were conducted.  Usually for test 
retest reliability it is recommended that the measure is repeated one to two weeks after it was 
initially administered (Nunnally & Bernstein, 1994).  However, for convenience the test 
retest was conducted four months after the initial administration as part of the RESPECT trial 
follow-up assessment.  This measure examines stigma over the last month so a longer test 
retest period is expected, however four months may have been too long.  As the SIMS is time 
intensive, the researchers were conscious of not overburdening the participant by completing 
an additional semi-structured interview.   Similarly, for the sensitivity of change analysis a 
seven month time period was utilised as part of the RESPECT study.  Although there is not as 
much explicit guidance on duration for sensitivity to change analysis, seven months is a long 
duration.  A further limitation was the moderate sample size used for psychometric testing.  
Test-retest reliability and sensitivity to change analysis used only 25 and 28 participants 
respectively.  Furthermore, the factor analysis was carried out with n=79 participants when it 
is often recommended  that 10 times per number of variables is advantageous. 
In conclusion, the SIMS is a reliable and valid outcome measure of stigma in psychosis.  As 
it is a semi-structured interview measure, it offers an important alternative to all of the other 
self-report outcome measures.  
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Table 1- Participant Demographics 
 
 
Demographic Mean (Standard Deviation) Range 
Age  36.489 ( 11.69) 18-62 
 Category N 
Patient status Inpatient 
Outpatient 
47 
32 
Gender Male 
Female 
59 
20 
Ethnicity Black heritage 
White heritage 
Asian heritage 
Other 
12 
52 
10 
5 
Diagnosis Schizophrenia 
Paranoid Schizophrenia 
Psychotic episode 
First Episode Psychosis 
Schizoaffective Disorder 
Recurrent Psychosis 
Persistent Delusional Disorder 
Drug Induced Psychosis 
25 
18 
19 
10 
2 
2 
2 
1 
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Table 2 – Pearson correlation coefficients, descriptive statistics and factor loadings for SIMS items 
 
 
 
 
 
 
 
 
 
 
 
*p<0.05, ** p<0.01 
 
 
 
 
 
 
 
 
 
 1 2 3 4 5 6 7 8 9 M SD Min Max S K Factor 
Loading 
1Percived          2.44 1.059 0 4 -.245 -.212 .762 
2Experienced .527**         1.57 1.195 0 4 .201 -.943 .683 
3Self-esteem .612** .472**        2.05 1.290 0 4 -.243 -.999 .844 
4Emotions .531** .511** .685**       2.41 1.296 0 4 -.547 -.747 .790 
5Behaviours .542** .398** .750** .604**      2.10 1.307 0 4 -.263 -.954 .816 
6Relationships .544** .603** .578** .599** .533**     1.96 1.275 0 4 -.118 -
1.156 
.794 
7 Symptoms .580** .345** .599** .449** .651** .513**    1.22 1.346 0 4 .598 -
1.103 
.743 
8Treatment .142 .417** .255* .270* .274* .336** .229*   .90 1.069 0 4 .916 -.207 .429 
9Positive  
Impacts 
-.257* -.175 -.240* -.212 -.213 -.257* -
.296** 
-.019  .95 .904 0 3 .421 -.970 -.354 
10Recovery .550* .446** .623** .603** .656** .608** .543** .388** -
.243* 
1.84 1.381 0 4 -.056 -
1.296 
.810 
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Table 3 – Descriptive of outcome measures at baseline and follow-up 
 Baseline Follow-up (7-months) 
 M SD Min Max S K M  SD 
 
Min 
 
Max 
 
S 
 
K 
1SIMS 19.53 8.73 2 36 -.082 -1.011 17.26 7.91 3 29 -.497 -.836 
2ISMI 69.85 16.74 32 104 -.458 -.157 65.47 19.02 0 98 -1.429 4.349 
3SS 31.03 10.93 9 58 -.024 -.420 35.80 8.92 13 51 -.591 .381 
4BDI 7.29 5.66 0 21 .475 -.686 6.88 4.82 0 14 -.109 -1.343 
5BHS 8.41 6.42 0 20 .459 -1.168 9.85 6.83 0 19 .010 -1.502 
6SERS 85.74 27.58 36 134 -.064 -1.045 78.16 27.34 33 131 .565 -.681 
7ISS 60.60 29.87 1 120 -.136 -.949 63.80 26.52 6 102 -.822 -.210 
8QPR 36.31 14.20 0 60 -.658 .098 35.28 12.94 7 60 -.319 .214 
S=Skewness, K=Kurtosis 
Table 4– Pearson Correlation Coefficients and descriptive statistics of outcome measures at baseline 
 
 N 1 2 3 4 5 6 7 
1SIMS 79        
2ISMI 78 .752**       
3SS 76 .666** .681**      
4BDI 77 .689** .646** .533**     
5BHS 76 .603** .566** .515** .800**    
6SERS 77 -.775** -.800** -.653** -.788** -.754**   
7ISS 63 .741** -.830** .678** .808** .719** -.908**  
8QPR 75 -.531** -.433** -.517 -.668** -.777** .657** -.688** 
*p<0.05, ** p<0.01 
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Table 5 – Pearson correlation coefficients and follow-up descriptive statistics for sensitivity to change analysis 
 N 1 2 3 4 5 6 7 
SIMS change 23        
ISMI change 28 .479*       
SS change 25 .571** .420*      
BDI change 25 .482* .255 .595**     
BHS change 25 .453* .083 .550** .713**    
SERS change 25 -.819** -.380 -.622** -.544** -.689**   
ISS change 25 .759** .439* .735** .592** .716** -.867**  
QPR change 25 -.659** -.140 -.590** -.654** -.681** .747** -.731** 
*p<0.05, ** p<0.01 
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Figure 1 – Scree plot of eigenvalues for Principal Components Analysis 
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Appendix 1: SERVICE-USER INTERVIEW MEASURE of STIGMA (SIMS) –  Simplified Interview 
Schedule 
 
1. Understanding of stigma: I was wondering if you would be able to tell me about your 
understanding of stigma? What does it mean to you? 
2. Perceived stigma: How do you think a person with ___________/ experiences of psychosis 
is viewed by society?  Are they viewed differently from someone who does not have 
___________/ experiences of psychosis?  In what way? 
3. Experienced Stigma from Psychosis:  Have you had any direct experiences of stigma 
because of ____________/ you have experiences of psychosis? 
4. Self-esteem: How do the public’s views about people who ___________-/ experience 
psychosis make you feel about yourself? How do your experiences of stigma/discrimination 
make you feel about yourself? Has it changed the way you think or feel about yourself?   
5. Emotional responses: How does stigma make you feel? Have you experienced any difficult 
emotions over the past month as a result of stigma? 
6. Safety behaviours/Avoidance: Do you think stigma has impacted upon your daily life?  How 
so? Does it stop you from doing things?  
7. Impacts on relationships: Do you think that your experiences of stigma have affected your 
relationships with others?  
8. Impacts on experiences of <psychosis> (positive symptoms): Have your experiences of 
stigma impacted on your ____________/ experiences of psychosis? Has it made your 
<experiences of psychosis> worse? 
9. Impacts on Treatment and accessing services: Has stigma affected you accessing mental 
health services? Has it affected your relationships with mental health professionals 
/services? Has it impacted upon your treatment?  
10. Positive impacts of stigma: Has stigma had any positive impacts on your day to day life?  
11. Recovery: What are your hopes for the future/recovery? What are your recovery goals? Do 
you think experiences of stigma have impacted on your recovery?  In what way / what 
aspects? 
 
